Paroxysmal nocturnal hemoglobinuria epidemiology and demographics
Paroxysmal nocturnal hemoglobinuria Microchapters |
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
FDA on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
CDC on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
Paroxysmal nocturnal hemoglobinuria epidemiology and demographics in the news |
Blogs on Paroxysmal nocturnal hemoglobinuria epidemiology and demographics |
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
The incidence of paroxysmal nocturnal hemoglobinuria is approximately 0.13 per 100,000 individuals worldwide. Paroxysmal nocturnal hemoglobinuria commonly affects adults. However, some cases of PNH in the childhood have been reported.
Epidemiology and Demographics
Incidence
- The incidence of paroxysmal nocturnal hemoglobinuria is approximately 0.13 per 100,000 individuals worldwide.[1]
Age
- Paroxysmal nocturnal hemoglobinuria commonly affects adults. However, some cases of PNH in the childhood have been reported.[2]
Race
- There is no racial predilection to [disease name].
Gender
- Paroxysmal nocturnal hemoglobinuria affects men and women equally.
References
- ↑ Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR; et al. (2010). "Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry". Cytometry B Clin Cytom. 78 (4): 211–30. doi:10.1002/cyto.b.20525. PMID 20533382.
- ↑ Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Small TN, Kobos R; et al. (2012). "Paroxysmal nocturnal hemoglobinuria in pediatric patients". Pediatr Blood Cancer. 59 (3): 525–9. doi:10.1002/pbc.23410. PMID 22147651.